Patrimony
The Louis Bachelier Group's patrimony has been defined as all the publications produced by academic researchers thanks to Group funding (ILB, FdR, IEF, Labex) or via the use of EquipEx data (BEDOFIH, EUROFIDAI).
Drugs, Showrooms and Financial Products: Competition and Regulation When Sellers Provide Expert Advice.
Decriminalization, Drugs
An economic analysis of the determinants of adolescent drug use.
Adolescence, Drogues, Drugs, Pairs, Peers, Plaisir, Politiques publiques, Prevention, Prévention, Public policies, Taxation
An economic analysis of addictive behaviors and drug policy in France.
Addictions, Addictive behaviors, Coût social, Drogues, Drugs, Drugs policy, Dual-process, Emotions, Nudges, Politiques publiques, Polyphasie cognitive, Rationality, Rationalité, Social cost
Is American Health Care Uniquely Inefficient? Evidence from Prescription Drugs.
Drugs
Orphan Drug Pricing In France: Influence of Main Factors.
Drugs, Health expenditures
How does Regulation Affect Beliefs? The Case of Stock Market Valuation of Orphan Drug Regulatory Approvals.
Drugs, Regulation